|
Originally published In Press as doi:10.1074/jbc.M204063200 on September 11, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47564-47571, December 6, 2002
Function and Solution Structure of Huwentoxin-IV, a Potent
Neuronal Tetrodotoxin (TTX)-sensitive Sodium Channel Antagonist from
Chinese Bird Spider Selenocosmia huwena*
Kuan
Peng,
Qin
Shu,
Zhonghua
Liu, and
Songping
Liang
From the College of Life Sciences, Hunan Normal University,
Changsha 410081, People's Republic of China
Received for publication, April 25, 2002, and in revised form, August 15, 2002
 |
ABSTRACT |
We have isolated a highly potent neurotoxin from
the venom of the Chinese bird spider, Selenocosmia huwena.
This 4.1-kDa toxin, which has been named huwentoxin-IV, contains 35 residues with three disulfide bridges: Cys-2-Cys-17,
Cys-9-Cys-24, and Cys-16-Cys-31, assigned by a chemical
strategy including partial reduction of the toxin and sequence analysis
of the modified intermediates. It specifically inhibits the
neuronal tetrodotoxin-sensitive (TTX-S) voltage-gated sodium
channel with the IC50 value of 30 nM in adult rat dorsal root ganglion neurons, while having no significant effect on
the tetrodotoxin-resistant (TTX-R) voltage-gated sodium channel. This
toxin seems to be a site I toxin affecting the sodium channel through a
mechanism quite similar to that of TTX: it suppresses the peak sodium
current without altering the activation or inactivation kinetics. The
three-dimensional structure of huwentoxin-IV has been determined by
two-dimensional 1H NMR combined with distant geometry
and simulated annealing calculation by using 527 nuclear
Overhauser effect constraints and 14 dihedral constraints. The
resulting structure is composed of a double-stranded antiparallel
-sheet (Leu-22-Ser-25 and Trp-30-Tyr-33) and four turns
(Glu-4-Lys-7, Pro-11-Asp-14, Lys-18-Lys-21 and Arg-26-Arg-29) and
belongs to the inhibitor cystine knot structural family. After comparison with other toxins purified from the same species, we are
convinced that the positively charged residues of loop IV (residues
25-29), especially residue Arg-26, must be crucial to its binding to
the neuronal tetrodotoxin-sensitive voltage-gated sodium channel.
 |
INTRODUCTION |
Voltage-gated sodium channels play important roles in electrical
signaling in almost all kinds of excitable tissues. They are
responsible for the generation of action potentials and nervous influx conduction in sensory nerves.
Although the pioneer investigation of tetrodotoxin
(TTX)1 on voltage-gated
sodium channels (VGSCs) had been performed by Narahashi et
al. (1, 2) in 1960s, it was not until early 1990s that people
began to classify the voltage-gated sodium channel into two different
types (3), tetrodotoxin-sensitive (TTX-S) VGSC and TTX-resistant
(TTX-R) VGSC. Further investigations on many other neurotoxins from
various biological sources such as ciguatoxin (4), scorpion toxins (5),
and µ-conotoxins (6-8) have shown that these toxins can affect VGSCs
through quite diverse mechanisms. At least six different sites have
been proposed to explain the complicated mechanisms of the
targeting VGSCs of these neurotoxins. In short, site I toxins such as
TTX and µ-conotoxins bind to an external key site of the pore so that
sodium ions can no longer pass the channel. Toxins related to sites
II-VI differ greatly from each other as they either affect the
activation ( -scorpion toxins) or the deactivation ( -scorpion
toxins) of sodium channels, and some of them even exert dual effects on
both processes (ciguatoxin) (9).
At the molecular level, the highly glycosylated -subunit (260 kDa)
is responsible for the pore forming of VGSCs. A number of
investigations on drug receptor/channel interaction have enabled us to
know many key residues for the function of VGSCs. TTX, saxitoxin, and
µ-conotoxins have contributed a great deal in probing the structure-function relationship and modulation of variant VGSCs (10-13).
Another potential striking use of VGSC antagonists comes from their
implication with pain. VGSCs expressed in primary sensory neurons (dorsal root ganglion (DRG) neurons) are believed to be important targets in the study of the molecular pathophysiology of pain
and in the search for new pain therapies (14-16). Peptide toxins with
considerable affinity and high selectivity to unique VGSCs are sure to
play an important role in this field.
In this study, we focus on the structure-function relationship
studies of a highly potent neurotoxin purified from Chinese bird
spider, Selenocosmia huwena, which is named huwentoxin-IV (HWTX-IV). First, we used patch clamp methods to investigate its effects on VGSCs expressed in adult rat DRG neurons; HWTX-IV
selectively inhibits TTX-S VGSCs and shows no significant effect on
TTX-R VGSCs. Second, its three-dimensional solution structure was
elucidated by using NMR methods; HWTX-IV shares an ancestral global
folding pattern with many other neurotoxins called the inhibitor
cystine knot (ICK) motif (17). Third, comparison with huwentoxin-I and previously known conotoxins bloking at site I provided us some clues on
its toxin-receptor interaction. Besides the disulfide-directed backbone, we think positively charged residues (residue Arg-26 especially) in the extrusive loop IV of the compact molecule must play
a crucial role in its targeting TTX-S VGSC.
 |
EXPERIMENTAL PROCEDURES |
Toxin Purification and Sequencing--
The venom from the female
Chinese bird spider (S. Huwena) was collected as described
in our previous work (18). HWTX-IV was purified by means of
ion-exchange and reverse-phase high performance liquid chromatography.
Lyophilized crude venom was loaded onto a Waters Protein-Pak CM 8HR
ion-exchange column (5 × 50 mm) initially equilibrated with 0.02 M sodium phosphate buffer, pH 6.25 (buffer A). The column
was eluted with a linear gradient of 0-50% of buffer B (1 M sodium chloride, 0.02 M sodium phosphate, pH
6.25) over 40 min at a flow rate of 0.7 ml min 1. The
fraction of interest was then applied to a Vydac C18 analytical reverse-phase HPLC column (218TP54, 4.6 × 250 mm) and eluted at a
flow rate of 0.8 ml min 1 using a gradient of 0-20%
buffer B (0.1% v/v trifluoroacetic acid in acetonitrile) over 8 min
after an equilibrium period of 2 min followed by a gradient of 20-35%
buffer B over 40 min. (Buffer A was 0.1% v/v trifluoroacetic acid in
water.) Once purified to >95% homogeneity (assessed by
reverse-phase HPLC and mass spectrometry), peptide was lyophilized and
stored at 20 °C until further use. The molecular mass was
determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) on a Bruker ProFlex-III mass spectrometer, and the entire amino acid sequence was obtained from
a single sequencing run on an Applied Biosystems/PerkinElmer Life
Sciences Procise 491-A protein sequencer.
Assignment of the Disulfide Bonds of Huwentoxin-IV by Partial
Reduction and Sequence Analysis (19-21)--
HWTX-IV (0.1 mg) was
solubilized in 10 µl of 0.1 mol/liter citrate buffer (pH 3)
containing 6 mol/liter guanidine-HCl. Partial reduction of HWTX-IV
disulfide bonds was carried out by adding 10 µl of 0.1 mol/liter Tris
(2-carboxyethyl) phosphine at 40 °C for 10 min at pH 3, and the
intermediates were isolated by reverse-phase HPLC (column: 218TP54,
4.6 × 250 mm) with linear gradient elution (20~35%
acetonitrile in 50 min). The intermediates of partial reduction were
collected, and their masses were determined by MALDI-TOF. Appropriate
intermediates containing free thiols were dried and then alkalized by
adding 100 µl of 0.5 mol/liter iodoacetamide (pH 8.3). The alkalized
peptide was desalted by reverse-phase HPLC and then submitted to an
Applied Biosystems Model 491 gas-phase sequencer. The Edman degradation
was performed with a normal automatic cycle program.
Insect Bioassay--
Insect toxicity was determined by
intraperitoneal injection of HWTX-IV into the abdomen of adult American
cockroaches Periplaneta americana at doses of 10-200 µg
g 1. Insects were monitored for 48 h after injection.
Cell Isolation Procedures--
Rat DRG neurons were acutely
dissociated and maintained in short term primary culture using the
method described by Hu and Li (22) Briefly, 30-day-old adult
Sprague-Dawley rats of either sex were decapitated, and the dorsal root
ganglia were isolated quickly from the spinal cord. Then they were
transferred into Dulbecco's modified Eagle's medium containing
trypsin (0.5 mg ml 1, type III, Sigma), collagenase (1.0 mg ml 1, type IA, Sigma), and DNase (0.1 mg
ml 1, type III, Sigma) for incubation at 34 °C for 30 min. Trypsin inhibitor (1.5 mg ml 1, type II-S, Sigma) was
used to terminate enzyme treatment. The DRG cells were transferred into
35-mm culture dishes (Corning, Sigma) with the cultured medium (95%
Dulbecco's modified Eagle's medium, 5% newborn calf serum,
hypoxanthine aminopterin thymidine supplement, and
penicillin-streptomycin) and incubated in CO2 incubator
(5% CO2, 95% air, 37 °C) for 1-4 h before the patch clamp experiment.
Electrophysiological Studies--
DRG cells with large diameters
(around 50 picosiemens in slow capacitance) and those with relatively
small diameters (around 20 picosiemens for slow capacitance)
were chosen for study of TTX-S and TTX-R sodium currents, respectively.
Meanwhile, TTX (final concentration at 0.2 µM) was used
to separate TTX-R sodium current from TTX-S sodium current.
Drug-containing solutions of 10-µl volume were applied by pressure
injection with a microinjector (IM-5B, Narishige, Tokyo, Japan) through
a micropipette (20-µm tip diameter) placed about 100 µm away from
the cells under study. Patch clamp experiments were performed at room
temperature (20-25 °C) under the whole cell patch clamp
configuration. Suction pipettes (2.0-3 microohms) were made of
borosilicate glass capillary tubes with a two-step pulling from a
vertical micropipette puller (PC-10, Narishige). The pipette
solution contained: 145 mM CsCl, 4 mM MgCl2·6H2O, 10 mM HEPES, 10 mM EGTA, 10 mM glucose, 2 mM ATP
(the pH was adjusted to 7.2 with KOH). The external solution contained: 145 mM NaCl, 2.5 mM KCl, 1.5 mM
CaCl2, 1.2 mM
MgCl2·6H2O, 10 mM HEPES, 10 mM glucose (the pH was adjusted to 7.4 with NaOH).
Experimental data were collected and analyzed by using the program
Pulse/Pulsefit 8.0(HEKA Electronics, Lambrecht/Pfalz, Germany), and
macroscopic TTX-S or TTX-R sodium currents were filtered at 10 kHz and
digitized at 3 kHz with an EPC-9 patch clamp amplifier (HEKA
Electronics, Germany). Series resistance was kept near 5 microohms and
compensated 65-70%, and linear capacitative and leakage currents were
digitally subtracted by using the P/4 protocol.
NMR Spectroscopy--
An NMR sample was prepared by dissolving
~10 mg of HWTX-IV in 500 µl of 20 mM phosphate buffer
(H2O/D2O, 9/1, v/v) containing 0.002% NaN3 and
0.1 mM EDTA. The pH was adjusted to 4.5 with HCl, and
sodium 3-(trimethyl-silyl) propionate-2, 2, 3, 3-D4 was added at a
final concentration of 200 µM as an internal chemical
shift reference. The final concentration of HWTX-IV was ~5
mM. For experiments in D2O, the sample used in
H2O experiments was lyophilized and then redissolved in 500 µl of 99.996% D2O (Cambridge Isotope Laboratories).
All NMR experiments were recorded on a 500 MHz Bruker DMX-500
spectrometer. All two-dimensional spectra were recorded in
phase-sensitive mode by the time-proportional phase incrementation
method following standard pulse sequences and phase cycling. Solvent
suppression was achieved by the presaturation method. Two-dimensional
NMR spectra were recorded at a temperature of 300 K, including COSY, DQF-COSY, and TOCSY with a mixing time of 37 and 73 ms, as well as
NOESY with a mixing time of 100, 200, and 300 ms. The recording data
points of t1 × t2 were 512 × 2048 for COSY and TOCSY,
700 × 4096 for DQF-COSY, and 512 × 2048 for all NOESY
spectra except 768 × 4096 for the 100 ms spectrum.
The hydrogen-deuterium exchange experiments were carried out by
recording a series of one-dimensional spectra after redissolving the
lyophilized H2O experiment sample in D2O at
time scalar of 10 min, 20 min, 30 min, 1 h, 2 h, 4 h,
6 h, 8 h, and 24 h. A TOCSY spectrum was recorded after
8 h of exchanging.
Spectra were processed and viewed using the software XWINNMR (Bruker)
or Felix 98.0 (Biosym Technologies) on the O2 work station (Silicon Graphics). All data were zero-filled to produce a 2K × 4K real matrix to COSY, DQF-COSY and NOESY or 1K × 2K to TOCSY. Before Fourier transformation, sine bell or sine bell square window functions were used with a phase shift of /2.
Structure Calculations--
Distance constraints were derived
from the intensities of cross-peaks in NOESY spectra with mixing times
of 100 or 200 ms. Observed NOE data were classified into strong,
medium, and weak, corresponding to upper bound interproton
distance restraints of 2.7, 3.5, and 5.0 Å, respectively. Lower
distance bounds were taken, and the sum of the van der Waals radii of
proton was 1.8 Å. Pseudo-atom corrections were applied to non-stereo
measurements specifically assigned to methyl and methylene protons
according to the method of Wüthrich (23).
Backbone dihedral constraints were derived from
3JHNH coupling constants measured from
either one-dimensional NMR spectra or the anti-phase cross-peak
splitting in a high digital resolution DQF-COSY spectrum. 14 dihedral angles were restrained to 120 ± 40 (degree) for a
3JHNH 8 Hz and 65 ± 25 (degree)
for 3JHNH 5.5 Hz.
HWTX-IV contains 6 cysteine residues paired as Cys-2-Cys-17,
Cys-9-Cys-24, and Cys-16-Cys-31, assigned by partial reduction and
sequence analysis. Nine additional fake distance constraints were added
to define the three disulfide bonds involved in HWTX-IV. For each
disulfide bond, three distance constraints, S(i) S(j), S(i) C (j), and S(j) C (i), were set to
2.02 ± 0.02, 2.99 ± 0.5, and 2.99 ± 0.5 Å,
respectively. Irredundant distance constraints derived from NOEs and
dihedral constraints derived from 3JHN
coupling constants have been used to calculate the structure of HWTX-IV
by distance geometry and simulated annealing calculation with the
program XPLOR (24).
 |
RESULTS |
Isolation and Sequencing of HWTX-IV--
HWTX-IV was purified by a
combined use of ion-exchange HPLC and reverse-phase HPLC as described
before (Fig. 1). Its molecular mass is
4107.5 Da, read from its mass spectrometry. The amino acid
sequence of HWTX-IV, as shown in Fig. 4, is composed of 35 amino acids
residues including six cysteine residues.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Purification of
HWTX-IV. The absorbent peak (retention time as 30.83) labeled with
a * symbol in ion-exchange chromatography was further purified with
reverse-phase HPLC as shown in the inset. The dashed
line in the inset displays the buffer B percentage in
the dilution gradient. HWTX-IV is washed out at 24% buffer
B.
|
|
Assignment of the Disulfide Bonds of Huwentoxin-IV by Partial
Reduction and Sequence Analysis--
Fig.
2 shows the HPLC separation of the
mixture obtained from the partial reduction under controlled reducing
conditions. Five chromatographic peaks contain intact peptide and
partially reduced intermediates, as determined by MALDI-TOF analysis.
The main peak (marked 1) represents intact HWTX-IV, whose
observed MALDI mass is the same as the calculated average mass of
native HWTX-IV. The mass of peak 2 has 2 Da more in comparison with
that of native HWTX-IV, indicating that peak 2 has one of the three disulfide bonds reduced. Peak 3 and peak 4 represent species that are
each 4 Da heavier than intact peptide, suggesting two reduced disulfide
bonds. Peak 5 represents completely reduced peptide, whose mass is 6 Da
heavier than intact HWTX-IV.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Analytical reverse-phase HPLC profile of
partial reduction of HWTX-IV by TCEP. Five chromatographic peaks
contain intact peptide and partially reduced intermediates,
respectively. The main peak (peak 1) represents intact
HWTX-IV, whose observed mass is the same as the native oxidized toxin.
Peak 2 with a mass 2 Da greater than that of native HWTX-IV
indicates one of the three disulfide bonds possibly reduced. The masses
of peak 3 and peak 4 are both 4 Da heavier than
intact peptide, suggesting that two disulfide bonds are reduced to four
free thiol groups. Peak 5 represents completely reduced
peptide with a mass 6 Da heavier than intact HWTX-IV.
|
|
Peaks 2-4 were collected and alkalized by adding iodoacetamide before
further purification by analytical reverse-phase HPLC. There is 58-Da
shift from the original molecular mass after the alkyl group was added
to single free thiol upon alkylation. The masses of the three alkalized
intermediates determined by MALDI-TOF correspond to the above molecular
mass results very well (data not shown).
In Fig. 3A, Pth-CM-Cys signal
was observed in the chromatograms at the 2nd and 17th cycles after
Edman degradation of alkalized peak 1, whereas no Pth-CM-Cys signals
were shown at other cysteine cycles. The above result indicates that
the only reduced disulfide bond is Cys-2-Cys-17. When
sequencing alkalized peak 3, Pth-CM-Cys signals were just observed in
the chromatograms at the 2nd, 16th, 17th, and 31st cycles in the HPLC
profiles of cysteine cycles (Fig. 3B), indicating that Cys-9
is still linked to Cys-24 by a disulfide bond.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
HPLC profiles of sequencing partial reduced
intermediates after modification with
iodoacetamide. Cysteine residues occur at cycles 2, 9, 16, 17, 24, and 31, indicate on the left of the panels. The elution
position of Pth-CM-Cys is marked with CM-Cys. A, the
cysteine residue cycles of alkylated peak 2. B, the cysteine
residue cycles of alkylated peak 3. C, the cysteine residue
cycles of alkylated peak 4.
|
|
For alkalized peak 4, Pth-CM-Cys signals were just observed
at the 2nd, 9th, 17th, and 24th sequencing cycles, as showed in Fig.
3C. The data indicate that the remaining disulfide bond is Cys-16-Cys-31.
All these results indicate that the disulfide linkage of HWTX-IV is
Cys-2-Cys-17, Cys-9-Cys-24, and Cys-16-Cys-31, adopting a
1-4, 2-5, 3-6 disulfide pattern. The amino acid sequence of HWTX-IV
is shown in Fig. 4.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Comparison of amino acid sequence of HWTX-IV
with HWTX-I and previously known conotoxins
(CTX) blocking at site I (O = 4-trans-L-hydroxyproline. The proposed key residues
important for their functions are displayed in the frame
boxes. Conotoxin GS (38, 39), µ-conotoxin PIIIA (6),
µ-conotoxin GIIIA (7, 35, 36), and µ-conotoxin GIIIB (8, 37) block
at site I. HWTX-I was suggested to be an N-type calcium
channel inhibitor (33). Like HWTX-IV and conotoxin GS, it adopts a
1-4, 2-5, 3-6 disulfide pattern and cystine knot motif (32).
|
|
Effects of HWTX-IV on Sodium Channel Currents--
It is widely
accepted that two different types of VGSCs exist in rat DRG neurons.
TTX-S sodium currents activate and inactivate quickly, whereas TTX-R
sodium currents activate and inactivate slowly. TTX at a dose of around
200 nM can suppress TTX-S sodium currents, but TTX-R sodium
currents remain almost unchanged at that dose.
When the membrane was held near its resting potential at
80 mV, TTX-S sodium currents were much more sensitive to the blocking action of HWTX-IV than TTX-R currents. HWTX-IV at a dose of 10 nM blocked 15-55% of the TTX-S sodium currents (Figs.
5a and 7), whereas TTX-R
sodium currents were left intact after the application of HWTX-IV at a
concentration up to 100 nM (Fig. 5b). The
effects of HWTX-IV on the current-voltage relationship are illustrated in Fig. 6. As can be seen from the
current-voltage curve, HWTX-IV blocked TTX-S sodium currents to the
same degree in the entire membrane potential range (Fig. 6,
a-c). No significant shift in current-voltage relationship
was observed. It seemed that HWTX-IV had no significant effect on TTX-R
sodium currents (Fig. 6, d-f). The inhibition of HWTX-IV on
TTX-S sodium currents was dose-dependent, and the
IC50 estimated from data collected from six to eight DRG neurons was about 30 nM (Fig.
7), which indicates a rather striking potency among all known VGSC antagonists.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Differential effects of HWTX-IV on TTX-R and
TTX-S sodium currents. a, TTX-R sodium current was elicited
by depolarizing the cell from a holding potential of 80 mV to 10
mV. The duration of the test pulse was 20 ms. 100 nM HWTX-IV did not observably alter the current recorded.
b, TTX-R sodium current was elicited by depolarizing the
cell from a holding potential of 80 mV to 20 mV. The duration of
the test pulse was 20 ms. 10 nM HWTX-IV caused a
significant decrease in peak current amplitude.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of HWTX-IV on I-V relationships of
TTX-S and TTX-R sodium currents. TTX-S (a and
b) and TTX-R (d and e) sodium currents
were recorded before and after the application of 100 nM
HWTX-IV. Currents were elicited by 20-ms test pulses from a holding
potential of 80 mV to variant potentials from 70 mV to 70 mV with
an increment of 10 mV. c and f, alterations in
I-V relationships resulted from the application of HWTX-IV for TTX-S
and TTX-R sodium currents, respectively.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Dose-dependent inhibition of
HWTX-IV on TTX-S sodium current. Currents were elicited by 20-ms
voltage steps to 20 mV. Cells with a rundown of sodium current above
5% in 3 min were excluded from further statistics. Data points
(mean ± S.E., six to eight cells per point) show currents
relative to control current amplitudes. The block was determined after
toxin had been applied for >1 min. The inset shows an
illustration of the gradual inhibition of HWTX-IV on peak amplitude of
TTX-S current in which peaks 1-6 represent the effect of
HWTX-IV at doses from 0.1 nM to 10 µM with a
10-fold increment.
|
|
Some peptide neurotoxins such as -scorpion toxins (5) and funnel-web
spider toxins (26-28) that interact with a variety of receptor sites
on the VGSC can produce repetitive firing of nerves. This symptom is
due to toxin-induced alteration in activation and/or inactivation
kinetics. Sodium channels are maintained in the open state, and thus
the prolonged depolarizing post-potential results in repetitive
activity. Unlike these toxins, HWTX-IV shows no effect on the
activation and inactivation kinetics of both TTX-S and TTX-R VGSCs. Its
action on TTX-S current is very similar to that of TTX. Thus it is
reasonable to take HWTX-IV as a site I toxin, although we have not
conducted an isotope-labeled toxin binding assay to test whether it
shares the same binding site with TTX.
Sequence-specific Resonance Assignments--
The sequence-specific
assignment of proton resonances was performed according to standard
procedures developed by Wüthrich (23). Spin systems for
methyl-containing residues such as Leu-3, Ile-5, Ala-8, Leu-22, Val-23,
Thr-28, and Ile-35 were identified through the combined analysis of
DQF-COSY, TOCSY, and NOESY spectra. They were used as the start points
for the sequential assignment process. The spin system of residue
Pro-11 was realized by the observation of strong NOE cross peaks
between the proton of Asn-10 and the proton of Pro-11, which
also suggests that residue Pro-11 in HWTX-IV takes the trans
configuration. All backbone and more than 95% of side chain proton
resonances belonging to spin systems for each of the 35 amino acid
residues were assigned. Fig. 8 shows the
sequential d N(i,i+1) connectivities on the
C H-NH fingerprint region of the NOESY spectrum with a mixing
time of 200 ms. Table I shows the summary
of the chemical shifts of proton resonances of HWTX-IV.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 8.
Sequential
d N(i,i+1) connectivities in the
C H-NH fingerprint region of the NOESY
spectrum. The mixing time of the NOESY spectrum is 200 ms.
Sequential d N connectivities are shown for residues
1-10 and 12-35. Residue 11 is a proline.
|
|
Structure Calculation and Evaluation--
527 irredundant distance
constraints derived from NOEs and 14 dihedral constraints derived from
3JHN coupling constants had been used to
calculate the structure of HWTX-IV by distance geometry and simulated
annealing calculation with the program XPLOR. The initial structures
were refined by two rounds of simulated annealing with force constants
50 kcal mol 1 Å 2 and 200 kcal
mol 1 rad 2 for NOE distance and dihedral
angel constraints, respectively. An ensemble of 20 structures with
lower energy and better Ramachandran plots were chosen to represent the
three-dimensional solution fold of HWTX-IV. NOE violations of all of
these 20 structures are less than 0.3 Å, and dihedral violations are
less than 2 degrees. The 20 structures exhibit no significant deviation
from ideal covalent geometry, satisfy the experiment constraints with
minimal violations, and have good non-bonded contacts as evidenced by the low values of the mean Lennard-Jones potential. Structural statistics are shown in Table II.
Analysis of the family of 20 structures using the program
PROCHECK (29) reveals that 81.6% of all the non-Pro/Gly residues lie
in the most favored regions of the Ramachandran plot, and the remaining
18.4% lie in the additionally allowed regions. The 20 structures
converged to a common fold; the root mean square differences
(R.M.S.D.) of 20 structures (pairwise comparison or versus
mean structure) are low (Table II).
The coordinates for the family of 20 structures and NMR constraints
file have been deposited in the Brookhaven Protein Data Bank (PDB) with
accession code 1MB6. The 1H chemical shifts have been
deposited in BioMagResBank (BMRB) with accession code RCSB016799.
Three-dimensional Structure of HWTX-IV--
Fig.
9A shows a stereo pair
representation of the best-fit superposition of the C trace for the
20 structures of HWTX-IV. The trace is colored from blue to white
according to increasing R.M.S.D. Analysis of the ensemble of 20 structures indicates that a main structural characteristic of HWTX-IV
is a double-stranded antiparallel -sheet (Fig. 9B), which
is formed by the strands Leu-22-Ser-25 and Trp-30-Tyr-33,
respectively. The information from the large
3JHNH coupling constants, chemical
shift index (CSI), slowly exchanging amide protons, strong sequential
d N and weak dNN, as well as interstrand NOE
connectivities also occurs with such a -sheet. Turns in HWTX-IV have
been identified by the standard that the distance between C (i) and
C (i+3) is less that 7 E and classified according to Richardson
(30). Four -turns have been found in the structure of HWTX-IV, as
shown in Table III and Fig. 9B. -turns 11-14, 17-20, and 26-29 are type I, and
turn 4-7 is type II.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 9.
Solution structure
characterization of HWTX-IV. A, stereo view of
superimposition of C atoms for the ensemble of 20 structures. The
color of the traces is brightened from blue to
white according to the increasing of R.M.S.D. B,
the schematic of HWTX-IV illustrates the location of secondary
structures. The -sheet is shown in yellow, turns are
shown in blue, and the random coil structure is shown in
green. Three disulfide bonds (Cys-2-Cys-17, Cys-9-Cys-24,
and Cys-16-Cys-31) are indicated. C, comparison of HWTX-IV
and HWTX-I (Protein Data Bank code: 1QK6). The C trace of HWTX-IV is
shown in green, and the C trace of HWTX-I in shown in
yellow.
|
|
HWTX-IV adopts an ICK motif commonly observed in toxic and inhibitory
polypeptides (17, 31). In HWTX-IV, the cystine knot is formed by three
disulfide bonds linking as Cys-2-Cys-17, Cys-9-Cys-24, and
Cys-16-Cys-31 in which the disulfide Cys-16-Cys-31 passes through a
16-residue ring formed by the other two disulfide bridges (Cys-2-Cys-17 and Cys-9-Cys-24) and the intervening polypeptide backbone. The amino acid sequence of the ICK fold in HWTX-IV can be
written as
CX6CX6CCX6CX6C,
where X is any amino acid residue. Structural comparison
shows that the R.M.S.D. between HWTX-IV and huwentoxin-I (HWTX-I) (Fig.
9C), a toxin purified from the same spider venom that also
adopts the ICK fold but shows inhibition on N-type Ca2+
channel current (33), is 1.31 Å for trace C atoms. It indicated that the three-dimensional structures of HWTX-IV and HWTX-I (Protein Data Bank code: 1QK6) are highly similar although their biological functions are completely different.
 |
DISCUSSION |
The Target of HWTX-IV--
Several potent toxins target
voltage-gated sodium channels; the different sites of binding and modes
of activity of these toxins are very significant for investigating the
structure and function of these sodium channels, which play a key role
in excitable tissues. TTX, an extensively investigated non-peptide
sodium channel blocker, targets a site generally postulated to be at
the extracellular end of the channel pore (site I). HWTX-IV shows no
effect on the activation and inactivation kinetics of both TTX-S and
TTX-R VGSCs, and its action on TTX-S current is very similar to that of
TTX. Thus it is reasonable to consider HWTX-IV as a site I toxin,
although we have not conducted an isotope-labeled toxin binding assay
to test whether it shares the same binding site with TTX. So far only
one family of polypeptide toxins, the µ-conotoxins from
Conus, has been shown to act at this site and functionally
affect voltage-gated sodium currents. The amino acid sequence of
HWTX-IV is quite different from that of µ-conotoxins, so it should
prove to be a novel useful ligand to investigate the multiple molecular
forms of voltage-gated sodium channels.
Structure-Activity Relationship of HWTX-IV--
Many research
groups have demonstrated that negatively charged residues of the sodium
channel are important in the binding of site I toxins to their targets,
and guanidinium groups in these toxins are of particular importance for
their actions on the sodium channel (6-8, 34-37). Studies of
µ-conotoxin GIIIA suggested that the largest activity loss was
introduced when Arg-13 or Arg-19 was replaced (36). Conotoxin GS binds
competitively with µ-conotoxin GIIIA to the sodium channel surface
(site I), but these two conotoxins have little sequence and structure
identity with one other (38, 39). Unlike µ-conotoxins, both conotoxin
GS and HNTX-IV adopt a cystine-knot motif with the same disulfide bond
pattern. Loop 4 of HWTX-IV looks like a flexible segment, and almost no
long distance or medium distance NOE constraint correlating with other sections of the toxin could be observed in its NMR spectra. The sequence alignment of these two toxins shows that Arg-26, which is
located in the flexible loop 4 of HWTX-IV, is conserved. Like all
toxins that block at site I, the guanidinium group of Arg is supposed
to be critical to the function of HWTX-IV.
Biological Implication of HWTX-IV--
HWTX-IV at a dose as high
as 200 µg g 1 showed no effect in the adult American
cockroach. Nor does it target VGSCs in cardiac or skeletal muscle of
both amphibians and mammals. It selectively inhibits neuronal TTX-S
VGSC in mammals, acting most likely as a site I antagonist. Such a
specificity is still unavailable from any other peptide toxin so far
known. Characterization of HWTX-IV and investigation of its interaction
with VGSCs are sure to provide us with insight into the gating
mechanism of neuronal sodium channels as well as the different roles of
diverse sodium channels in signal integration in the nervous system.
Both TTX-S VGSCs and TTX-R VGSCs in DRG neurons are involved in the
pain pathway. However, for different kinds of pain symptoms, their
involvements seem to be of variant degrees. Furthermore, the delicate
cooperation between these two subtypes might be of equal importance to
that pathway as well (25). Now that HWTX-IV selectively blocks
the TTX-S sodium current in DRG neurons, it is hoped that it can be
applied in pain therapy. Actually, judged by our preliminary
experiments, it does introduce a significant upgrade to the pain
threshold in rats (data not shown).
In summary, we have found a highly potent neurotoxin, huwentoxin-IV,
that specifically inhibits the neuronal tetrodotoxin-sensitive voltage-gated sodium channel. This toxin seems to be a site I toxin,
like µ-conotoxins (6-8, 36, 37), affecting the sodium channel
through a mechanism quite similar to that of TTX. The three-dimensional
structure of HWTX-IV determined by two-dimensional 1H NMR
proved that the molecule adapted a typical ICK motif. It should prove
to be a novel ligand useful to investigate the multiple molecular forms
of voltage-gated sodium channels.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Jihui Wu (University of Science
and Technology of China) for collecting two-dimensional NMR spectra and
Weijun Hu (Hunan Normal University) for the peptide sequence analysis. We are grateful to Prof. Jinyung Xie (Hunan Normal University) and Dr.
Shanyun Lu (Peking University) for the helpful discussions.
 |
FOOTNOTES |
*
This work was supported by the National Natural Science
Foundation of China (Grants 30170193 and 39990600).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1MB6) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed. Fax:
86-731-886-1304; E-mail: liangsp@public.cs.hn.cn.
Published, JBC Papers in Press, September 11, 2002, DOI 10.1074/jbc.M204063200
 |
ABBREVIATIONS |
The abbreviations used are:
TTX, tetrodotoxin;
TTX-R, TTX-resistant;
TTX-S, TTX-sensitive;
DRG, dorsal
root ganglion;
VGSC, voltage-gated sodium channel;
HWTX-IV, huwentoxin
IV;
ICK, inhibitor cystine knot;
Pth, parathyroid hormone;
CM, carboxymethyl;
R.M.S.D., root mean square difference(s);
HPLC, high
pressure liquid chromatography;
MALDI-TOF MS, matrix-assisted laser
desorption/ionization-time of flight mass spectrometry;
NOE, nuclear
Overhauser effect;
NOESY, NOE spectroscopy;
DQF, double quantum
filtered;
TOCSY, two-dimensional total correlation spectroscopy.
 |
REFERENCES |
| 1.
|
Narahashi, T.,
Deguchi, T.,
Urakama, N.,
and Ohkubo, Y.
(1960)
Am. J. Physiol.
198,
934-938[Abstract/Free Full Text]
|
| 2.
|
Narahashi, T.,
Moore, J. W.,
and Scott, W. R.
(1964)
J. Gen. Physiol.
47,
965-974[Abstract/Free Full Text]
|
| 3.
|
Roy, M. L.,
and Narahashi, T.
(1992)
J. Neurosci.
12,
2104-2111[Abstract]
|
| 4.
|
Strachan, L. S.,
Lewis, R. J.,
and Nicholson, G. M.
(1998)
J. Pharmacol. Exp. Ther.
288,
379-388[Abstract/Free Full Text]
|
| 5.
|
Possani, L. D.,
Becerril, B.,
Delepierre, M.,
and Tytgat, J.
(1999)
Eur. J. Biochem.
264,
287-300[Medline]
[Order article via Infotrieve]
|
| 6.
|
Shon, K. J.,
Oliver, M. B.,
Watkins, M.,
Jacobsen, R. B.,
Gray, W. R.,
Floresca, C. Z.,
Cruz, L. J.,
Hillyard, D. R.,
Brink, A.,
Terlau, H.,
and Yoshikami, D.
(1998)
J. Neurosci.
18,
4473-4481[Abstract/Free Full Text]
|
| 7.
|
Chahine, M.,
Sirois, J.,
Marcotte, P.,
Chen, L. Q.,
and Kallen, R. G.
(1998)
Biophys. J.
75,
236-246[Medline]
[Order article via Infotrieve]
|
| 8.
|
Li, R. A.,
Ennis, I. L.,
Vélez, P.,
Tomaselli, G. F.,
and Marbàn, E.
(2000)
J. Biol. Chem.
275,
27551-27558[Abstract/Free Full Text]
|
| 9.
|
Meir, A.,
Ginsburg, S.,
Butkevich, A.,
Kachalsky, S. G,
Kaiserman, I.,
Ahdut, R.,
Demirgoren, S.,
and Rahamimoff, R.
(1999)
Physiol. Rev.
79,
1019-1087[Abstract/Free Full Text]
|
| 10.
|
Sampo, B.,
Tricaud, N.,
Leveque, C.,
Seagar, M.,
Couraud, F.,
and Dargent, B.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3666-3671[Abstract/Free Full Text]
|
| 11.
|
Boccaccio, A.,
Moran, O.,
Irnoto, K.,
and Conti, F.
(1999)
Biophys. J.
77,
229-240[Medline]
[Order article via Infotrieve]
|
| 12.
|
Penzotti, J. L.,
Fozzard, H. A.,
Lipkind, G. M.,
and Dudley, S. C.
(1998)
Biophys. J.
75,
2647-2657[Medline]
[Order article via Infotrieve]
|
| 13.
|
Hilber, K.,
Sandtner, W.,
Kudlacek, O.,
Glaaser, I. W.,
Weisz, E.,
Kyle, J. W.,
French, R. J.,
Fozzard, H. A.,
Dudley, S. C.,
and Todt, H.
(2001)
J. Biol. Chem.
276,
27831-27839[Abstract/Free Full Text]
|
| 14.
|
Waxman, S. G.,
Dib-Hajj, S.,
Cummins, T. R.,
and Black, J. A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7635-7639[Abstract/Free Full Text]
|
| 15.
|
Porreca, F.,
Lai, J.,
Bian, D.,
Wegert, S.,
Ossipov, M. H.,
Eglen, R. M.,
Kassotakis, L.,
Novakovic, S.,
Rabert, D. K.,
Sangameswaran, L.,
and Hunter, J. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7640-7644[Abstract/Free Full Text]
|
| 16.
|
Cummins, T. R.,
and Waxman, S. G.
(1997)
J. Neurosci.
17,
3503-3514[Abstract/Free Full Text]
|
| 17.
|
Pallaghy, P. K.,
Nielsen, K. J.,
Craik, D. J.,
and Norton, R. S.
(1994)
Protein Sci.
3,
1833-1839[Medline]
[Order article via Infotrieve]
|
| 18.
|
Shu, Q.,
and Liang, S.
(1999)
J. Pept. Res.
53,
486-491[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Wu, J.,
and Watson, J. T.
(1997)
Protein Sci.
6,
391-398[Medline]
[Order article via Infotrieve]
|
| 20.
|
Gray, W. R.
(1993)
Protein Sci.
2,
1732-1748[Medline]
[Order article via Infotrieve]
|
| 21.
|
Gray, W. R.
(1993)
Protein Sci.
2,
1749-1755[Medline]
[Order article via Infotrieve]
|
| 22.
|
Hu, H. Z.,
and Li, Z. W.
(1997)
J. Physiol.
501,
67-75[Abstract/Free Full Text]
|
| 23.
|
Wüthrich, K.
(1986)
NMR of Proteins and Nucleic Acids
, John Wiley & Sons, Inc., New York
|
| 24.
|
Brünger, A. T.
(1992)
X-PLOR Manual, Version 3.1.
, Yale University, New Haven, CT
|
| 25.
|
Waxman, S. G.
(1999)
Pain
6 (suppl.),
S133-S140
|
| 26.
|
Nicholson, G. M.,
Willow, M.,
Howden, M. E. H.,
and Narahashi, T.
(1994)
Eur. J. Physiol.
428,
400-409[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Nicholson, G. M.,
Little, M. J.,
Tyler, M.,
and Narahashi, T.
(1996)
Toxicon
34,
1443-1453[Medline]
[Order article via Infotrieve]
|
| 28.
|
Nicholson, G. M.,
Walsh, R.,
Little, M. J.,
and Tyler, M.
(1998)
Eur. J. Physiol.
436,
117-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Laskowski, R. A.,
MacArthur, M. W.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Appl. Cryst.
26,
283-291
|
| 30.
|
Richardson, J. S.
(1981)
Adv. Protein Chem.
34,
167-236[Medline]
[Order article via Infotrieve]
|
| 31.
|
Norton, R. S.,
and Pallaghy, P. K.
(1998)
Toxicon
36,
1573-1583[Medline]
[Order article via Infotrieve]
|
| 32.
|
Zhang, D.,
and Liang, S.
(1993)
J. Protein Chem.
12,
735-740[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Peng, K.,
Chen, X.,
and Liang, S.
(2001)
Toxicon
39,
491-498[Medline]
[Order article via Infotrieve]
|
| 34.
|
Rogers, J. C., Qu, Y. S.,
Tanada, T. N.,
Scheuer, T.,
and Catterall, W. A.
(1996)
J. Biol. Chem.
271,
15950-15962[Abstract/Free Full Text]
|
| 35.
|
Li, R. A.,
Ennis, I. L.,
French, R. J.,
Dudley, S. C., Jr.,
Tomaselli, G. F.,
and Marbàn, E.
(2001)
J. Biol. Chem.
276,
11072-11077[Abstract/Free Full Text]
|
| 36.
|
Sato, K.,
Ishida, Y.,
Wakamatsu, K.,
Kato, R.,
Honda, H.,
Ohizumi, Y.,
Nakamura, H.,
Ohya, M.,
Lancelin, J. M.,
Kohda, D.,
and Inagaki, F.
(1991)
J. Biol. Chem.
266,
16989-16991[Abstract/Free Full Text]
|
| 37.
|
Hill, J. M.,
Alewood, P. F.,
and Craik, D. J.
(1996)
Biochemistry
35,
8824-8835[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Hill, J. M.,
Alewood, P. F.,
and Craik, D. J.
(1997)
Structure
5,
571-583[Medline]
[Order article via Infotrieve]
|
| 39.
|
Yanagawa, Y.,
Abe, T.,
Satake, M.,
Odani, S.,
Suzuki, J.,
and Ishikawa, K.
(1988)
Biochemistry
27,
6256-6262[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Xiao, J.-P. Bingham, W. Zhu, E. Moczydlowski, S. Liang, and T. R. Cummins
Tarantula Huwentoxin-IV Inhibits Neuronal Sodium Channels by Binding to Receptor Site 4 and Trapping the Domain II Voltage Sensor in the Closed Configuration
J. Biol. Chem.,
October 3, 2008;
283(40):
27300 - 27313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Martin-Moutot, P. Mansuelle, G. Alcaraz, R. G. D. Santos, M. N. Cordeiro, M. E. De Lima, M. Seagar, and C. Van Renterghem
Phoneutria nigriventer Toxin 1: A Novel, State-Dependent Inhibitor of Neuronal Sodium Channels That Interacts with {micro} Conotoxin Binding Sites
Mol. Pharmacol.,
June 1, 2006;
69(6):
1931 - 1937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liu, J. Dai, L. Dai, M. Deng, Z. Hu, W. Hu, and S. Liang
Function and Solution Structure of Huwentoxin-X, a Specific Blocker of N-type Calcium Channels, from the Chinese Bird Spider Ornithoctonus huwena
J. Biol. Chem.,
March 31, 2006;
281(13):
8628 - 8635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bosmans, L. Rash, S. Zhu, S. Diochot, M. Lazdunski, P. Escoubas, and J. Tytgat
Four Novel Tarantula Toxins as Selective Modulators of Voltage-Gated Sodium Channel Subtypes
Mol. Pharmacol.,
February 1, 2006;
69(2):
419 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, Y. Xiao, X. Xu, X. Xiong, S. Lu, Z. Liu, Q. Zhu, M. Wang, X. Gu, and S. Liang
Structure-Activity Relationships of Hainantoxin-IV and Structure Determination of Active and Inactive Sodium Channel Blockers
J. Biol. Chem.,
September 3, 2004;
279(36):
37734 - 37740.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|